shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > News > World News > Article > No evidence of increased blood clot risk found AstraZeneca

No evidence of increased blood clot risk found: AstraZeneca

Updated on: 16 March,2021 09:38 AM IST  |  London
Agencies |

Many countries have suspended use of the COVID-19 jab developed by the British-Swedish firm

No evidence of increased blood clot risk found: AstraZeneca

Municipal police patrol at the Piazza della Rotonda square in central Rome, on Monday. PIC/AFP

In the wake of several European countries suspending the use of the AstraZeneca COVID-19 vaccine, the company has said that there has been no evidence of increased blood clot risk from its jab. The suspensions have come amid several reports of blood clots following vaccinations with the COVID-19 jab developed by the British-Swedish pharmaceutical giant and the University of Oxford.


“Safety is of paramount importance and the company is continually monitoring the safety of its vaccine,” the company said in a statement. “A careful review of all available safety data of more than 17 million people vaccinated in the EU and UK with COVID-19 vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” it added.


So far across the EU and UK, there have been 15 events of DVT and 22 events of pulmonary embolism reported among those given the vaccine, based on the number of cases the company has received as of 8 March, AstraZeneca said. The company said that this is much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed COVID-19 vaccines.


British Airways to introduce vaccine passports
British Airways (BA) will introduce digital vaccine passports in time for the return of international travel in May, when Britons are allowed to travel for their holidays, a media report said on Sunday. The airline will ask those who have had two doses of a Coronavirus vaccine to log their vaccination details with their BA app, said a media report.

Biden, Harris to start COVID-19 plan tour


President Joe Biden, Vice President Kamala Harris and their spouses are opening an ambitious, cross-country tour this week to highlight the benefits of his $1.9 trillion plan to defeat the Coronavirus and boost the economy.  The road show — dubbed the ‘Help is Here — tour by the White House’ — begins on Monday.

Ireland recommends suspension of AstraZeneca vaccine
Irish health officials on Sunday recommended the temporary suspension of the AstraZeneca vaccine after reports of serious blood clotting after inoculations in Norway. Dr Ronan Glynn, Ireland’s deputy chief medical officer, said the recommendation was made after Norway’s medicines agency reported four cases of blood clotting in adults after receiving the AstraZeneca vaccine.

S Korea to give first jab to 12 mn people by June end
South Korean health authorities said on Monday that the country aims to administer the first jab of COVID-19 vaccines to 12 million people by the end of June. The country launched its mass vaccination campaign on February 26, administering the first shot of vaccines to a total of 588,958 people, mostly patients aged 65 or lower at nursing homes and medical staff treating COVID-19 patients, Xinhua news agency reported.

2,44,236
No. of new cases reported globally in the past 24 hours

11,99,64,144
Total no. of cases worldwide

26,55,477
Total no. of deaths worldwide

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK